Analysts’ Updated EPS Estimates for January 6th (CNQ, FNF, LPTH, MAR, MI.UN, NKE, NVS, SHOP, SOFI, SYF)

Analysts’ updated eps estimates for Tuesday, January 6th:

Canadian Natural Resources (TSE:CNQ) (NYSE:CNQ) was downgraded by analysts at Evercore Partners from an outperform rating to an in-line rating. The firm currently has C$50.00 price target on the stock.

Fidelity National Financial (NYSE:FNF) had its price target lowered by Barclays PLC from $64.00 to $63.00. Barclays PLC currently has an equal weight rating on the stock.

LightPath Technologies (NASDAQ:LPTH) had its target price increased by Lake Street Capital from $10.00 to $14.00. They currently have a buy rating on the stock.

Marriott International (NASDAQ:MAR) had its price target boosted by Sanford C. Bernstein from $329.00 to $369.00. The firm currently has an outperform rating on the stock.

Minto Apartment Real Estate Invt Trust (TSE:MI.UN) was downgraded by analysts at CIBC from an outperform rating to a neutral rating. CIBC currently has C$18.00 target price on the stock, up from their previous target price of C$17.00.

Minto Apartment Real Estate Invt Trust (TSE:MI.UN) was downgraded by analysts at Canaccord Genuity Group Inc. from a buy rating to a hold rating. The firm currently has C$18.00 target price on the stock, up from their previous target price of C$15.50.

NIKE (NYSE:NKE) had its buy rating reaffirmed by analysts at Sanford C. Bernstein. The firm currently has a $85.00 price target on the stock.

Novartis (NYSE:NVS) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating.

Shopify (NASDAQ:SHOP) (TSE:SHOP) was upgraded by analysts at Wolfe Research from a peer perform rating to an outperform rating.

Bank of America Corporation began coverage on shares of SoFi Technologies (NASDAQ:SOFI). Bank of America Corporation issued an underperform rating and a $20.50 price target on the stock.

Synchrony Financial (NYSE:SYF) had its target price raised by Barclays PLC from $86.00 to $101.00. The firm currently has an overweight rating on the stock.

Teva Pharmaceutical Industries (NYSE:TEVA) had its target price raised by Jefferies Financial Group Inc. from $29.00 to $40.00. Jefferies Financial Group Inc. currently has a buy rating on the stock.

Taysha Gene Therapies (NASDAQ:TSHA) had its buy rating reissued by analysts at Chardan Capital. The firm currently has a $12.00 target price on the stock.